Viking Therapeutics, Inc. (VKTX)
31.58
+0.78
(+2.53%)
USD |
NASDAQ |
May 27, 15:45
Viking Therapeutics Free Cash Flow : -340.33M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 10.37B |
| Amgen, Inc. | 8.597B |
| Catalyst Pharmaceuticals, Inc. | 208.13M |
| Altimmune, Inc. | -71.67M |
| TG Therapeutics, Inc. | -14.19M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -113.98M |
| Cash from Investing (Quarterly) | 54.19M |
| Cash from Financing (Quarterly) | 12.08M |
| Free Cash Flow Per Share (Quarterly) | -0.9862 |
| Free Cash Flow to Equity (Quarterly) | -113.84M |
| Free Cash Flow to Firm (Quarterly) | -113.98M |
| Free Cash Flow Yield | -9.49% |